Cabaletta Bio (CABA) Consolidated Net Income (2018 - 2025)

Cabaletta Bio's Consolidated Net Income history runs 8 years deep, the most recent figure standing at -$41.8 million for Q4 2025.

• In Q4 2025, Consolidated Net Income fell 28.4% year-over-year to -$41.8 million; the TTM figure through Dec 2025 stood at -$168.2 million (down 45.18% YoY), while the FY2025 annual figure was -$168.2 million, down 45.18% from the prior year.
• Consolidated Net Income was -$41.8 million for Q4 2025 at Cabaletta Bio, up from -$45.4 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of -$9.7 million in Q1 2021 to a low of -$45.4 million in Q3 2025.
• Historically, Consolidated Net Income has averaged -$22.6 million across 5 years, with a median of -$16.2 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Consolidated Net Income climbed 1.15% in 2022, then tumbled 90.53% in 2024.
• A 5-year view of Consolidated Net Income shows it stood at -$13.9 million in 2021, then fell by 12.99% to -$15.7 million in 2022, then tumbled by 33.1% to -$20.9 million in 2023, then tumbled by 56.02% to -$32.6 million in 2024, then fell by 28.4% to -$41.8 million in 2025.
• The last three Consolidated Net Income figures came in at -$41.8 million (Q4 2025), -$45.4 million (Q3 2025), and -$45.1 million (Q2 2025), per Business Quant data.